论文部分内容阅读
CT引导组织间介入近距离治疗学
【出 处】
：
北京大学医学部近距离放疗研究中心成立大会暨北京大学第三届国际放射肿瘤学术论坛
【发表日期】
：
2013年12期
其他文献
目的 探讨重组人腺病毒p53 (rAd-p53)对不同p53-mdm2反馈环状态的宫颈癌细胞放射敏感性影响.方法 先采用Western blot法检测了两种宫颈癌细胞系(Siha细胞系和C33a细胞系)初始p53和mdm2状态,然后,以rAd-p53分别感染含野生型p53基因的宫颈癌细胞Siha和含突变型p53基因的宫颈癌细胞C33a,测定经rAd-p53处理后不同时间p53表达水平的变化.采用W
Feasibility Study of Volumetric Modulated Arc Therapy with Constant Dose Rate for Endometrial Cancer
Purpose: To investigate the feasibility, efficiency, and delivery accuracy of volumetric modulated arc therapy with constant dose rate (VMAT-CDR) for whole pelvic radiotherapy of endometrial cancer.Ma
Smart Arc-based Volumetric Modulated Arc Therapy for Endometrial Cancer:a Dosimetric Comparison with
Purpose: To investigate the feasibility of volumetric modulated arc therapy with SmartArc (VMAT-S) for endometrial cancer to achieve equivalent plan quality with higher delivery efficiency, against in
Study of Electronic Portal Imaging Device for Dosimetric Verification of Intensity-modulated Radiati
Purpose: To investigate the feasibility and efficiency of electronic portal imaging device for dosimetric verification of intensity-modulated radiation therapy.Methods: 10 patients treated with intens
会议
目的 探讨重组人p53腺病毒瘤内注射后p53基因和靶基因的表达.方法 选择2005年9月-2006年12月在我院接受重组人p53腺病毒制剂."今又生"(Gendicine)治疗和放疗的恶性肿瘤患者25例,在基因治疗前和治疗后48小时,通过鼻咽镜活检或在B超引导下穿刺活检获取肿瘤标本,每次取三份标本,一份标本用于检查病理,一份用于免疫组化检测P53,P21,Bax和VEGF蛋白；另一份则用于p53m
Direct Effects of 125I Seeds Radiation on A549 Lung Cancer Cells:G2/M Arrest and Enhanced Cell Death
Introduction External beam radiation (EBRT) and 125I seed continuous low dose rate radiation (CLDR)were used to treat patients with lung cancer.The reasons for the improved therapy of CLDR were not fu
目的 评价重组人p53腺病毒注射液(rAd-p53)结合放疗治疗晚期软组织肉瘤的疗效及安全性.方法 自2001年10月至2013年01月,采用重组人p53腺病毒制剂(Gendicine商品名：今又生)结合放疗共治疗晚期软组织肉瘤36例.其中,男19例,女17例,年龄段17～75岁,平均48.5±19.0岁.全部病例经病理证实为软组织肉瘤,其中腹膜后脂肪肉瘤5例,横纹肌肉瘤6例,纤维肉瘤7例,恶性神
China-Canada Education Consortium A Collaborative Program Brining Innovation to Practice in Radiatio
会议
Three Dimensional Non-coplanar Conformal Radiotherapy with 75Gy/25fr/5w Regimen for The Treatment of
Purpose: Three-dimensional non-coplanar conforrnal radiotherapy (3-DNCCRT) has recently been considered promising for the treatment of stage Ⅰ non-small cell lung cancer (NSCLC).Usually, it is perform